Busca avançada
Ano de início
Entree
(Referência obtida automaticamente do Web of Science, por meio da informação sobre o financiamento pela FAPESP e o número do processo correspondente, incluída na publicação pelos autores.)

Isoniazid: A Review of Characteristics, Properties and Analytical Methods

Texto completo
Autor(es):
dos Santos Fernandes, Guilherme Felipe ; Salgado, Herida Regina Nunes ; dos Santos, Jean Leandro
Número total de Autores: 3
Tipo de documento: Artigo de Revisão
Fonte: CRITICAL REVIEWS IN ANALYTICAL CHEMISTRY; v. 47, n. 4, p. 298-308, 2017.
Citações Web of Science: 8
Resumo

Isoniazid is a synthetic antimicrobial and one of the most important first-line drugs used in the treatment of tuberculosis. Since it was introduced in the therapy in 1952, the drug remains at the front line of the antituberculosis treatment mainly due to its potency and high selectivity against Mycobacterium tuberculosis. Pharmaceutical analysis and therapeutic drug monitoring of isoniazid in both, pharmaceuticals and biological samples, plays an important role to comprehend aspects regarding to bioavailability, bioequivalence and therapeutic monitoring during patients following-up. In the last case, validated and simple methods are extremely useful for Public Healthy in order to guarantee the drug efficacy, safety and reduce the tuberculosis resistance. Among the available analytical tools, HPLC-based methods coupled to ultraviolet or mass spectroscopy are the most widely used techniques to quantify isoniazid. Therefore, this review highlights the main analytical methods reported in the literature for determination of isoniazid focusing in HPLC-based methods. (AU)

Processo FAPESP: 14/02240-1 - Planejamento, Síntese e Avaliação Anti Mycobacterium tuberculosis de Novos Derivados N-óxidos
Beneficiário:Guilherme Felipe dos Santos Fernandes
Modalidade de apoio: Bolsas no Brasil - Mestrado
Processo FAPESP: 16/09502-7 - Planejamento, síntese e atividade antituberculose de novas oxazolidinonas úteis ao tratamento da tuberculose multirresistente
Beneficiário:Guilherme Felipe dos Santos Fernandes
Modalidade de apoio: Bolsas no Brasil - Doutorado